Search for: All records

Artificial Intelligence (AI) has demonstrated strong potential in automating medical imaging tasks, with potential applications across disease diagnosis, prognosis, treatment planning, and posttreatment surveillance. However, privacy concerns surrounding patient data remain a major barrier to the widespread adoption of AI in clinical practice, as large and diverse training datasets are essential for developing accurate, robust, and generalizable AI models. Federated Learning offers a privacy-preserving solution by enabling collaborative model training across institutions without sharing sensitive data. Instead, model parameters, such as model weights, are exchanged between participating sites. Despite its potential, federated learning is still in its early stages of development and faces several challenges. Notably, sensitive information can still be inferred from the shared model parameters. Additionally, postdeployment data distribution shifts can degrade model performance, making uncertainty quantification essential. In federated learning, this task is particularly challenging due to data heterogeneity across participating sites. This review provides a comprehensive overview of federated learning, privacy-preserving federated learning, and uncertainty quantification in federated learning. Key limitations in current methodologies are identified, and future research directions are proposed to enhance data privacy and trustworthiness in medical imaging applications 

Surgical pathology reports contain essential diagnostic information, in free-text form, required for cancer staging, treatment planning, and cancer registry documentation. However, their unstructured nature and variability across tumor types and institutions pose challenges for automated data extraction. We present a consensus-driven, reasoning-based framework that uses multiple locally deployed large language models (LLMs) to extract six key diagnostic variables: site, laterality, histology, stage, grade, and behavior. Each LLM produces structured outputs with accompanying justifications, which are evaluated for accuracy and coherence by a separate reasoning model. Final consensus values are determined through aggregation, and expert validation is conducted by board-certified or equivalent pathologists. The framework was applied to over 4,000 pathology reports from The Cancer Genome Atlas (TCGA) and Moffitt Cancer Center. Expert review confirmed high agreement in the TCGA dataset for behavior (100.0%), histology (98.5%), site (95.2%), and grade (95.6%), with lower performance for stage (87.6%) and laterality (84.8%). In the pathology reports from Moffitt (brain, breast, and lung), accuracy remained high across variables, with histology (95.6%), behavior (98.3%), and stage (92.4%), achieving strong agreement. However, certain challenges emerged, such as inconsistent mention of sentinel lymph node details or anatomical ambiguity in biopsy site interpretations. Statistical analyses revealed significant main effects of model type, variable, and organ system, as well as model × variable × organ interactions, emphasizing the role of clinical context in model performance. These results highlight the importance of stratified, multi-organ evaluation frameworks in LLM benchmarking for clinical applications. Textual justifications enhanced interpretability and enabled human reviewers to audit model outputs. Overall, this consensus-based approach demonstrates that locally deployed LLMs can provide a transparent, accurate, and auditable solution for integrating AI-driven data extraction into real-world pathology workflows, including cancer registry abstraction and synoptic reporting. 

Abstract BackgroundDiagnostic pathology depends on complex, structured reasoning to interpret clinical, histologic, and molecular data. Replicating this cognitive process algorithmically remains a significant challenge. As large language models (LLMs) gain traction in medicine, it is critical to determine whether they have clinical utility by providing reasoning in highly specialized domains such as pathology. MethodsWe evaluated the performance of four reasoning LLMs (OpenAI o1, OpenAI o3-mini, Gemini 2.0 Flash Thinking Experimental, and DeepSeek-R1 671B) on 15 board-style open-ended pathology questions. Responses were independently reviewed by 11 pathologists using a structured framework that assessed language quality (accuracy, relevance, coherence, depth, and conciseness) and seven diagnostic reasoning strategies. Scores were normalized and aggregated for analysis. We also evaluated inter-observer agreement to assess scoring consistency. Model comparisons were conducted using one-way ANOVA and Tukey’s Honestly Significant Difference (HSD) test. ResultsGemini and DeepSeek significantly outperformed OpenAI o1 and OpenAI o3-mini in overall reasoning quality (p < 0.05), particularly in analytical depth and coherence. While all models achieved comparable accuracy, only Gemini and DeepSeek consistently applied expert-like reasoning strategies, including algorithmic, inductive, and Bayesian approaches. Performance varied by reasoning type: models performed best in algorithmic and deductive reasoning and poorest in heuristic and pattern recognition. Inter-observer agreement was highest for Gemini (p < 0.05), indicating greater consistency and interpretability. Models with more in-depth reasoning (Gemini and DeepSeek) were generally less concise. ConclusionAdvanced LLMs such as Gemini and DeepSeek can approximate aspects of expert-level diagnostic reasoning in pathology, particularly in algorithmic and structured approaches. However, limitations persist in contextual reasoning, heuristic decision-making, and consistency across questions. Addressing these gaps, along with trade-offs between depth and conciseness, will be essential for the safe and effective integration of AI tools into clinical pathology workflows.